We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-45.00 | -2.97% | 1,469.00 | 1,463.00 | 1,469.00 | 1,469.00 | 1,365.00 | 1,453.00 | 160,160 | 12:08:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 983.11 | 1.97B |
By Adria Calatayud
Indivior PLC said Monday that it believes a claimed filed by Reckitt Benckiser Group PLC against it is without merit and vowed to fully and vigorously defend itself in any proceedings related to the claim.
The U.K. pharmaceutical company on Friday said a claim for 1.07 billion pounds ($1.42 billion) against it had been submitted to the Commercial Court in London by consumer-goods giant Reckitt Benckiser on Nov. 13. Indivior said the claim relates to an indemnity contained in a 2014 demerger agreement between it and Reckitt Benckiser.
The claim hasn't been served on Indivior at the present time, the company said.
Indivior noted comments by Reckitt Benckiser in The Times of London and Financial Times newspapers that it "regularly takes certain procedural steps to preserve potential claims."
Indivior said it believes it has strong grounds for defending against the claim should it be served, based on the information available to the company.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
November 30, 2020 02:54 ET (07:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions